Found 2 articles for: "Papulopustular"

Topical Aprepitant (HT-001): A Novel Therapy for Epidermal Growth Factor Receptor Inhibitor-Associated Papulopustular Eruptions
September 2024 | Volume 23 | Issue 9 | Case Reports | e173 | Copyright © September 2024
Papulopustular eruptions are the most common dermatologic side effect of epidermal growth factor receptor inhibitor (EGFRI) therapy. Topical corticosteroids and oral tetracyclines are frequently ...
Read More
Topical Ivermectin Is Associated With Improved Erythematotelangiectatic, Papulopustular, and Phymatous Rosacea in a Secondary Analysis
October 2023 | Volume 22 | Issue 10 | Editorials | 1063 | Copyright © October 2023
Rosacea has variable clinical presentation consisting of four overlapping phenotypes: erythematotelangiectatic, papulopustular, phymatous, and ocular.¹ Rosacea's pathogenesis involves incre...
Read More